A $1 million challenge, on behalf of the Centers for Disease Control and Prevention, to enhance testing for lead in children.

Five Phase 2 teams showcased their development of advanced point-of-care blood lead tests at Demo Day on October 24, 2024.
Lead Detect Prize

Phase 2 winners

Meridian Bioscience

First-place winner Meridian Bioscience is using electrochemical sensors to detect lead by measuring the electrical current in a blood sample.

OndaVia

Second-place winner OndaVia is applying optical technology to detect the presence of lead using a distinctive fingerprint signature.

GlucoSentient and UT Austin

Third-place winner GlucoSentient is adapting a blood glucose meter platform and using a DNAzyme sensor to detect lead in a blood sample.

About the challenge

The Lead Detect Prize seeks to accelerate the development of next-generation point-of-care blood lead testing technology. The challenge, on behalf of the Centers for Disease Control and Prevention, will advance blood lead test solutions by providing funding and expertise while fostering collaboration and partnership. Phase 1 awarded five winners an equal share of a $150,000 prize pool. Phase 1 winners were also exclusively invited to enter Phase 2 and participated in a virtual accelerator. Three Phase 2 winners were awarded a share of a $850,000 Phase 2 prize pool.

Timeline

In Phase 2, three winners were announced live at a Demo Day and awarded a share of $850,000.

Challenge launch

November 14, 2023

Phase 1 submission deadline

January 22, 2024

Phase 1 evaluation

January 23-February 23, 2024

Phase 1 winner announcement and Phase 2 start

March 14, 2024

Phase 2 submission period ends

August 8, 2024
We are here

Phase 2 Demo Day and winner announcement

October 2024

PRIZE POOL

$1 million

The Lead Detect Prize awarded $1 million. Phase 1 awarded $150,000, and Phase 2 awarded a further $850,000.

Challenge resources

Access resources to learn more about the current issues in blood lead exposure testing and how to take a novel test from concept through regulatory approval and commercialization.